# Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy

> **NCT00229437** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 343 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** TAK-128
- **DRUG:** TAK-128
- **DRUG:** TAK-128
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00229437
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229437, "Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00229437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*